← Back to Directory

Drugs Made In America Acquisition II Corp. (DMII) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Drugs Made In America Acquisition II Corp. (DMII).

Get it on Google Play Download on Google Play Download on the App Store Download on the App Store

Equity Details

Price & Market Data

Price: $10.07

Daily Change: +$0.01 / 0.10%

Daily Range: $10.06 - $10.07

Market Cap: $641,459,008

Daily Volume: 46,009

Performance Metrics

1 Week: 0.20%

1 Month: 0.50%

3 Months: 0.70%

6 Months: 1.93%

1 Year: 1.93%

YTD: 1.62%

About Drugs Made In America Acquisition II Corp. (DMII)

Stay informed about Drugs Made In America Acquisition II Corp. (DMII). Price: 10.07, daily change: +$0.01 / 0.10%. Market cap: 641,459,008. Detailed performance for all key periods.

Company Details

Employees: 2

Sector: Finance

Industry: Financial conglomerates

Country: United States

Details

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Selected stocks

Cardinal Infrastructure Group Inc. (CDNL)

HCM IV Acquisition Corp. (HACQ)

QuasarEdge Acquisition Corporation (QRED)

AMASS Brands Inc. (AMSS)

Inflection Point Acquisition Corp. VI (IPFX)